| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |